Senior Fellow Greg Conko breaks down the fight over Avastin, a drug used to treat several types of cancer. The FDA is poised to rescind Avastin’s approval for treating breast cancer. It will retain its approval for other cancers. This will…
Senior Fellow Greg Conko breaks down the fight over Avastin, a drug used to treat several types of cancer. The FDA is poised to rescind Avastin’s approval for treating breast cancer. It will retain its approval for other cancers. This will…
Your host Richard Morrison welcomes back guest co-hosts William Yeatman and the Capital Research Center’s Jeremy Lott for episode 57. We start with Blue Dogs and health care legislation, cash for clunkers running on fumes, and AT&T’s response to an iPhone controversy. We continue…
